Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children-Reference-Cited by-同舟云学术

Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children

Published:2022-05-04 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Qiu Yan¹^ORCID,Wu Zi-Kang²,Wu Jie³,Yao Jun⁴,Liu Ying¹^ORCID,Ren Wen¹^ORCID,Sun Yu-Jing¹,Shen Ling-Zhi⁴,Ren Jing-Jing¹^ORCID

Affiliation:

1. Department of General Practice, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

2. Department of Scientific Research, Women’s Hospital, School of Medicine Zhejiang University, Hangzhou, China

3. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

4. Department of Immunization Program Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China

Funder

the National Scientific and Technological Major Project of China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2061247

Reference25 articles.

1. WHO. Hepatitis B. 2021 Jul 27 [accessed 2021 Dec 12]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b

2. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity

3. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

4. Eliminating mother-to-child transmission of HBV: progress and challenges in China

5. The global burden of liver disease: The major impact of China